Announcements Trials
Browse Landscape

Phase

Phase 2 178Phase 1 73Phase 3 38Phase 1/2 38Phase NA 20Phase EARLY_PHASE1 10Phase 4 4Phase 2/3 4

Status

Unknown 3Completed 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 26Other hematologic neoplasm 23Breast 11Myeloid 5Plasma cell 4Classical hematology 3Sarcoma 2Other neoplasm 2Dermatologic 2Thoracic 1Head & Neck 1CNS 1

Conditions

Multiple Myeloma 4Leukemia 1

Interventions

Dexamethasone 8daratumumab 5Lenalidomide 5Bortezomib 5Trimethoprim, Sulfamethoxazole Drug Combination 4Thalidomide 4Cyclophosphamide 4gamma-Globulins 3Ciprofloxacin 3carfilzomib 2Melphalan 2Immunoglobulins, Intravenous 2Calcium Dobesilate 2Amoxicillin-Potassium Clavulanate Combination 2trametinib 1tanespimycin 1pomalidomide 1pazopanib 1fludarabine 1dabrafenib 1cobimetinib 1Whole-Body Irradiation 1Vemurafenib 1Stem Cell Transplantation 1Rivaroxaban 1Radiotherapy 1Radiation 1Pharmaceutical Preparations 1Mesna 1MAGEA3 protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Cyclophosphamide × Plasma cell × Clear all
NCT03759093 2023-09-06

CURATE.AI Optimized Modulation for Multiple Myeloma

National University Hospital, Singapore

Phase 2/3 Unknown
20 enrolled
Plasma cell

Multiple Myeloma

NCT00177047 2021-11-09

Autologous Transplant for Multiple Myeloma

Masonic Cancer Center, University of Minnesota

Phase 2/3 Completed
363 enrolled 25 charts
Plasma cell

Multiple Myeloma

NCT03385096 2020-02-25

Mel vs BUCY+VP-16 Conditioning Regimen for MM Undergoing Auto-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Unknown
122 enrolled
Plasma cell

Multiple Myeloma

NCT02270307 2014-10-21

MSC-CY

National Research Center for Hematology, Russia

Phase 2/3 Unknown
40 enrolled
Other hematologic neoplasmPlasma cell

Leukemia, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡